Pulmatrix (NASDAQ:PULM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report sent to investors on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. Pulmatrix Price Performance Shares of NASDAQ:PULM opened at $5.75 on Thursday. The firm’s 50 day simple moving average is $3.89 and its 200 […]

Leave a Reply

Your email address will not be published.

Previous post Financial Comparison: 180 Life Sciences (NASDAQ:ATNF) vs. Corbus Pharmaceuticals (NASDAQ:CRBP)
Next post ClearSign Technologies (NASDAQ:CLIR) Research Coverage Started at StockNews.com